![]() |
Volumn 4, Issue 5, 1999, Pages 209-221
|
Strategies for the control of LPS-mediated pathophysiological disorders
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 ACETOXYMETHYL 3 [7 [[1 (N,N DIMETHYLCARBAMOYL) 6 (4 FLUOROPHENYL) 3 INDOLYL]CARBONYL] 1H,3H PYRROLO[1,2 C]THIAZOL 3 YL]PYRIDINIUM CHLORIDE;
ADENINE DERIVATIVE;
ADRENALIN;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIINFLAMMATORY AGENT;
AZUROCIDIN;
BACTERIUM LIPOPOLYSACCHARIDE;
CD14 ANTIGEN;
CENTOXIN;
CL 184005;
COMPLEMENT;
CYTOKINE;
DT 5461;
E 5531;
EDOBACOMAB;
ENDOTOXIN;
ENDOTOXIN ANTIBODY;
GINKGOLIDE B;
KININ DERIVATIVE;
L 161240;
LIPID A;
LIPOPHORIN;
LISOFYLLINE;
MONOCLONAL ANTIBODY T88;
NEUROTRANSMITTER;
NEUTRALIZING ANTIBODY;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE INHIBITOR;
PENTOXIFYLLINE;
PLASMINOGEN ACTIVATOR INHIBITOR;
POLYMYXIN B;
RECEPTOR;
SDZ 219800;
SDZ 880431;
SDZ MRL 953;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
DRUG RESEARCH;
ENDOTOXEMIA;
GRAM NEGATIVE BACTERIUM;
GRAM NEGATIVE SEPSIS;
HOST RESISTANCE;
HUMAN;
IMMUNOREACTIVITY;
MORTALITY;
NONHUMAN;
PATHOPHYSIOLOGY;
REVIEW;
SEPTIC SHOCK;
SIGNAL TRANSDUCTION;
SYMPTOMATOLOGY;
TISSUE INJURY;
|
EID: 0033136960
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(99)01336-7 Document Type: Review |
Times cited : (34)
|
References (108)
|